| pubmed-article:8556702 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C0242957 | lld:lifeskim |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C0476089 | lld:lifeskim |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C0029005 | lld:lifeskim |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C0442726 | lld:lifeskim |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:8556702 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:8556702 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8556702 | pubmed:dateCreated | 1996-2-26 | lld:pubmed |
| pubmed-article:8556702 | pubmed:abstractText | HER-2/neu (c-erbB-2) oncoprotein is a transmembrane glycoprotein and may function as a growth factor receptor being involved in the regulation of cell growth and cell transformation. We performed an analysis of 100 patients with endometrial cancer stage FIGO I to IV using an immunoperoxidase technique on formalin-fixed, paraffin-embedded tissue samples in order to determine HER-2/neu oncoprotein expression. HER-2/neu oncoprotein was expressed in the tumors of 21 patients (21%). Clinical stage, histologic stage, histologic grade and death of invasion did not correlate with HER-2/neu oncoprotein expression. We found HER-2/neu oncoprotein in all clinical stages and therefore it does not seem to be a late event in the natural history of endometrial cancer. HER-2/neu oncoprotein expression was associated with poor overall survival (log-rank P-value 0.04). | lld:pubmed |
| pubmed-article:8556702 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8556702 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8556702 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8556702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8556702 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8556702 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8556702 | pubmed:issn | 0304-3835 | lld:pubmed |
| pubmed-article:8556702 | pubmed:author | pubmed-author:LoeschAA | lld:pubmed |
| pubmed-article:8556702 | pubmed:author | pubmed-author:BreiteneckerG... | lld:pubmed |
| pubmed-article:8556702 | pubmed:author | pubmed-author:GitschGG | lld:pubmed |
| pubmed-article:8556702 | pubmed:author | pubmed-author:KainzCC | lld:pubmed |
| pubmed-article:8556702 | pubmed:author | pubmed-author:KoelblHH | lld:pubmed |
| pubmed-article:8556702 | pubmed:author | pubmed-author:KohlbergerPP | lld:pubmed |
| pubmed-article:8556702 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8556702 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:8556702 | pubmed:volume | 98 | lld:pubmed |
| pubmed-article:8556702 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8556702 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8556702 | pubmed:pagination | 151-5 | lld:pubmed |
| pubmed-article:8556702 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:meshHeading | pubmed-meshheading:8556702-... | lld:pubmed |
| pubmed-article:8556702 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8556702 | pubmed:articleTitle | Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer. | lld:pubmed |
| pubmed-article:8556702 | pubmed:affiliation | Department of Gynecology, Vienna University Medical School, Austria. | lld:pubmed |
| pubmed-article:8556702 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8556702 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8556702 | lld:pubmed |
